BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 7525819)

  • 1. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
    Li Y; Ke Y; Gottlieb PD; Kapp JA
    J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Rock KL; Gamble S; Rothstein L
    Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
    Chen W; Carbone FR; McCluskey J
    J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
    Kovacsovics-Bankowski M; Clark K; Benacerraf B; Rock KL
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4942-6. PubMed ID: 8506338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
    Rock KL; Rothstein L; Fleischacker C; Gamble S
    J Immunol; 1992 May; 148(10):3028-33. PubMed ID: 1578128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways.
    Ke Y; McGraw CL; Hunter RL; Kapp JA
    Cell Immunol; 1997 Mar; 176(2):113-21. PubMed ID: 9073383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
    Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
    Pooley JL; Heath WR; Shortman K
    J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.
    Mitsui H; Inozume T; Kitamura R; Shibagaki N; Shimada S
    J Invest Dermatol; 2006 Aug; 126(8):1804-12. PubMed ID: 16645583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.
    Nakanishi T; Hayashi A; Kunisawa J; Tsutsumi Y; Tanaka K; Yashiro-Ohtani Y; Nakanishi M; Fujiwara H; Hamaoka T; Mayumi T
    Eur J Immunol; 2000 Jun; 30(6):1740-7. PubMed ID: 10898512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
    Carbone FR; Bevan MJ
    J Exp Med; 1990 Feb; 171(2):377-87. PubMed ID: 2137512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovalbumin-specific, MHC class I-restricted, alpha beta-positive, Tc1 and Tc0 CD8+ T cell clones mediate the in vivo inhibition of rat IgE.
    MacAry PA; Holmes BJ; Kemeny DM
    J Immunol; 1998 Jan; 160(2):580-7. PubMed ID: 9551891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.
    Kim KW; Kim SH; Jang JH; Lee EY; Park SW; Um JH; Lee YJ; Lee CH; Yoon S; Seo SY; Jeong MH; Lee ST; Chung BS; Kang CD
    Cancer Immunol Immunother; 2004 Apr; 53(4):315-22. PubMed ID: 14685778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.